人参对与COVID-19相关的抑郁症的治疗潜力和可能的机制
Fangyi Zhao1,2,3, Kai Zhang1,2,3, Hongyu Chen1,2,3
1Jilin Provincial Key Laboratory on Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun, People's Republic of China.
Inflammopharmacology
|November 27, 2023
概括
人参可能有助于缓解COVID-19感染后的抑郁和疲劳等精神症状. 这篇评论探讨了人参.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- COVID-19 (2019年冠状病毒疾病) 感染与精神病症状如抑郁症,认知障碍和疲劳有关.
- 炎症因素在急性COVID-19和持续的后急性综合征中发挥着作用.
- 这些神经心理症状与全身和中枢神经系统的炎症相关.
研究的目的:
- 为了审查COVID-19肺炎的机制.
- 为了检查冠状病毒感染后的精神症状.
- 为了探索人参对COVID后精神症状的潜在益处.
主要方法:
- 关于COVID-19病变发生的文献综述.
- 对COVID后精神病症状研究的分析.
- 检查人参的药理性质和对炎症和免疫系统的影响.
主要成果:
- 人参表现出抗炎,免疫调节和神经内分泌作用.
- 这些特性表明,在COVID后的条件下,治疗抑郁症,疲劳和不安的潜在治疗价值.
- 人参可能提供一种自然方法来缓解神经和心理并发症.
结论:
- 人参的多方面的行动为解决COVID-19的精神病后果提供了一个有希望的途径.
- 需要进一步的研究来阐明人参在后COVID综合征中的精确机制和临床疗效.
- 像人参这样的天然产品可以在患者的支持性护理中发挥作用,这些患者经历了SARS-CoV-2感染的长期神经和心理影响.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
Depression: Overview
252
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
252


